Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Oxford University
Pharma
AstraZeneca's COVID nasal vax flunks Oxford study
AstraZeneca's COVID-19 nasal spray candidate has come up short in an early-stage trial, failing to produce a strong immune response.
Kevin Dunleavy
Oct 11, 2022 10:10am
UK looks to recoup $278M by selling vax manufacturing site
Nov 29, 2021 10:15am
AZ's COVID vaccine largely distrusted in Europe, not U.K.; study
Mar 11, 2021 10:38am
AZ's Mexico vaccine partner forced to overhaul its factory
Feb 18, 2021 9:40am
Manufacturing may muddy AZ’s case for COVID shot at FDA: analyst
Feb 17, 2021 10:07am
AZ, Oxford kick off work on COVID vaccine booster shot
Feb 8, 2021 8:25am
